Revenue growth of leading 25 domestic drug firms is expected to moderate to 8-10 per cent in the next fiscal year, rating ...
The U.S. Food and Drug Administration has extended its review of Applied Therapeutics' experimental drug to treat ...
The FDA has approved a groundbreaking deal that could see Americans paying far less for their medical needs, as the state of ...
STAT Plus: Medicare couldn’t cover Wegovy for weight loss. But now that it’s also a heart drug, the door is open ...